Arizona, Florida, California, and others have seen record numbers of daily new coronavirus positives in the last couple of weeks, and that’s not just a reflection of more testing. Hospitalizations are up too.

The company behind a now-discredited study on hydroxychloroquine also posted a report that has been cited by Latin American governments recommending ivermectin as a possible coronavirus treatment. Clinicians there say the effects have been extremely damaging.

After stating that asymptomatic individuals are unlikely to transmit the novel coronavirus, World Health Organization officials clarify that this is very much an open question.

Milder, cold-causing members of this pathogenic viral family long remained under the radar, although they aren’t entirely harmless.

Pretending to be a javelin aficionado is one thing. Professing to have real insight into the ongoing pandemic is quite another.

Scientists have raised questions about the dataset published in The Lancet last week that triggered the suspension of clinical trials around the world—and about Surgisphere Corporation, the company behind the study.

Bluetooth-enabled technology will attempt to track people’s interactions on the British island—and potentially elsewhere in the UK—as lockdowns are lifted.

Preprints from the first round of seroprevalence studies indicate that many more people have been infected with the virus than previously reported. Some of these studies also have serious design flaws.

The most common preexisting conditions among the patients were diabetes, obesity, and hypertension.